Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2014
08/07/2014US20140220126 Abuse-deterrent pharmaceutical compositions for controlled release
08/07/2014US20140220125 Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors
08/07/2014US20140220124 Combination tablet with chewable outer layer
08/07/2014US20140220123 Pharmaceutical compositions comprising niacin and a process for their preparation
08/07/2014US20140220121 Novel formulation of diclofenac
08/07/2014US20140220120 Crystal entecavir, crystal entecavir formulation and methods for the preparation thereof
08/07/2014US20140220119 Capsules Containing High Doses of Levodopa for Pulmonary Use
08/07/2014US20140220118 Solid formulations of ospemifene
08/07/2014US20140220116 Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
08/07/2014US20140220115 Nanoparticle arsenic-platinum compositions
08/07/2014US20140220114 Methods for treating niemann-pick type c disease
08/07/2014US20140220113 Method and Medicament for Inhibiting the Expression of a Given Gene
08/07/2014US20140220112 Transformation of drug cyclodextrin complex compositions into compositions of mixtures of lipid vesicle encapsulated drug and cyclodextrin drug complexes
08/07/2014US20140220110 Remote loading of sparingly water-soluble drugs into liposomes
08/07/2014US20140220109 Novel cochleate formulations
08/07/2014US20140220108 Cochleate compositions and methods of making and using same
08/07/2014US20140220104 Patch containing rivastigmine
08/07/2014US20140220101 Substantially dry nicotinamide pads for treatment of skin inflammation
08/07/2014US20140220094 Methods and compositions for a laparoscopic surgery
08/07/2014US20140220063 Vaccine composition
08/07/2014US20140220058 Vaccine composition for transdermal or mucosal administration
08/07/2014US20140220057 Wt1 peptide cancer vaccine composition for transdermal administration
08/07/2014US20140220052 Compositions and methods for wound healing, and for recruitment and activation of macrophages in injured tissues and in implanted biomaterials used for tissue engineering
08/07/2014US20140220050 Novel immunomodulator and anti-inflammatory compounds
08/07/2014US20140220049 Microrna inhibition for the treatment of inflammation and myeloproliferative disorders
08/07/2014US20140220041 Compounds for use in the treatment of alzheimer's disease
08/07/2014US20140220036 Methods for treating neurodegenerative diseases and for identifying agents useful for treating neurodegenerative diseases
08/07/2014US20140220033 Administration of an Anti-Activin-A Compound to a Subject
08/07/2014US20140220032 Ddr2 mutations as targetable features of melanoma or basal cell carcinoma
08/07/2014US20140220030 Use of cgrp antagonist compounds for treatment of psoriasis
08/07/2014US20140220006 Lung cancer biomarkers
08/07/2014US20140220004 Compositions and methods for treating pain
08/07/2014US20140220001 Methods and Monitoring of Treatment with a DLL4 Antagonist
08/07/2014US20140220000 Mhc engagement and clip modulation for the treatment of disease
08/07/2014US20140219996 Ruthenium carbon monoxide releasing molecules and uses thereof
08/07/2014US20140219995 Inhibitors of bacterial type iii secretion system
08/07/2014US20140219989 Factor ixa inhibitors
08/07/2014US20140219967 Poly (3-Hydroxybutyrate/3-Hydroxyvalerate) of Lowered Crystallinity for Use in Animal Feed
08/07/2014US20140219966 Fecal lactoferrin as a biomarker for determining disease severity and for treating infection in patients with clostridium difficile disease
08/07/2014US20140219964 Methods for inducing cardiomyocyte proliferation
08/07/2014US20140219962 Porous chitosan scaffolds and related methods
08/07/2014US20140219961 Pharmaceutical composition for treating cancer, comprising interferon alpha conjugate
08/07/2014US20140219960 Novel composition for preventing or treating hepatitis c virus, regulating phosphorylation of replicase
08/07/2014US20140219958 5, 6-d2 uridine nucleoside/tide derivatives
08/07/2014US20140219957 Methods and compositions for the treatment of immune disorders
08/07/2014US20140219956 Pro-drug form (p2pdox) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer
08/07/2014US20140219952 Methods of treatment using stem cell mobilizers
08/07/2014US20140219951 Amido-amine dendrimer compositions
08/07/2014US20140219950 Enhanced transport using membrane disruptive agents
08/07/2014US20140219949 Pharmaceutical compositions comprising iodine and steroid and uses thereof for sinus diseases
08/07/2014US20140219935 Topical bioadhesive formulations
08/07/2014US20140219933 Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease
08/07/2014US20140219931 P-menthane-3,8-diol isomer mixture, cooling sensation composition comprising the same, and product comprising the cooling sensation composition
08/07/2014US20140219929 Oleaginous pharmaceutical and cosmetic foam
08/07/2014US20140219928 Topical oily foam compositions
08/07/2014US20140219923 Biodegradable compositions suitable for controlled release
08/07/2014US20140219917 Oligosaccharide conjugates for targeting bacteria and uses related thereto
08/07/2014US20140219914 Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity
08/07/2014DE102013001888A1 Vorrichtung und Verfahren zur Bereitstellung eines Atemgasstromes Apparatus and method for providing a breathing gas flow
08/06/2014EP2762569A1 Ngf aptamer and application thereof
08/06/2014EP2762480A1 Oxazolidinone antibiotics containing fused ring
08/06/2014EP2762479A1 Biaryl heterocycle substituted oxazolidinon antibacterial drug
08/06/2014EP2762476A1 1,2,4-triazine-6-carboxamide derivative
08/06/2014EP2762475A1 Pharmaceutically acceptable salts of quinolinone compounds and their medical use
08/06/2014EP2762472A2 Selenophene-fused aromatic compound and manufacturing method thereof
08/06/2014EP2762469A1 Crystal of 5-hydroxy-1h-imidazole-4-carboxamide hydrate, crystal of 5-hydroxy-1h-imidazole-4-carboxamide 3/4 hydrate, and method for producing same
08/06/2014EP2762466A1 Phenyl derivative
08/06/2014EP2762144A1 Inhibitor for corneal epithelial cell death, inhibitor characterized by combining hyaluronic acid and flavin adenine dinucleotide
08/06/2014EP2762143A1 Compositions comprising 15-OHEPA and methods of using the same
08/06/2014EP2762142A1 Compositions for treating cancer
08/06/2014EP2762141A1 Drug for the treatment of allergic rhinitis comprising pgd2 antagonist and histamine antagonist
08/06/2014EP2762140A1 Treatment of solid brain tumours with a rapamycin derivative
08/06/2014EP2762139A1 Anti-fungal agent
08/06/2014EP2762138A1 Pharmaceutical substance (variants) and compositions based thereon which exhibit modulatory activity with a commensurate effect
08/06/2014EP2762137A1 Use of myricetin or derivatives thereof as a cathepsin k inhibitor
08/06/2014EP2762136A1 Methods of stimulating cellular growth, synaptic remodeling and consolidation of long-term memory
08/06/2014EP2762135A1 Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients
08/06/2014EP2762134A1 Composition for treatment of pathogens that are resistant to tetracyclines
08/06/2014EP2762132A1 Controlled Release 25-Hydroxyvitamin D
08/06/2014EP2762124A1 Packaging comprising administration units of polymorphs, amorphous forms or solvates
08/06/2014EP2761019A1 Inhibitors of nox4 expression and/or nox4 function and their use in the prevention and treatment of nerve injury and/or neuropathic pain
08/06/2014EP2761002A1 Inhibition of microrna-134 for the treatment of seizure-related disorders and neurologic injuries
08/06/2014EP2760878A1 Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and use thereof for production of medicaments
08/06/2014EP2760875A1 Synthesis of hmo core structures
08/06/2014EP2760872A1 Compounds for the treatment of hepatitis c
08/06/2014EP2760871A1 Oxy-cyclohexyl-4h,6h-5-oxa-2,3,10b-triaza-benzo[e]azulenes as v1a antagonists
08/06/2014EP2760870A1 Substituted bicyclic heteroaryl compounds
08/06/2014EP2760868A1 Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation
08/06/2014EP2760867A1 Macrocyclic flt3 kinase inhibitors
08/06/2014EP2760866A1 Derivatives of 6-substituted triazolopyridazines as rev-erb agonists
08/06/2014EP2760865A2 Novel heterocyclic derivatives and their uses
08/06/2014EP2760864A1 5 - benzylaminomethyl - 6 - aminopyrazolo [3, 4 -b]pyridine derivatives as cholesteryl ester -transfer protein (cetp) inhibitors useful for the treatment of atherosclerosis
08/06/2014EP2760863A1 Pyrazolo[4,3-c]pyridine derivatives as kinase inhibitors
08/06/2014EP2760861A1 Crystalline hydrochloride salt of (1- (4 -fluorophenyl) - 1h - indol - 5 - yl) - (3- (4- (thiazole - 2 - carbonyl) piperazin- 1 - yl) az etidin- 1 -yl) methanone and its use in the treatment of pain and metabolic disorders
08/06/2014EP2760860A2 Nitrogen mustard derivatives
08/06/2014EP2760859A1 Crystalline forms of azilsartan and preparation and uses thereof
08/06/2014EP2760858A1 Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders
08/06/2014EP2760857A1 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
08/06/2014EP2760856A1 Selective nr2b antagonists
08/06/2014EP2760854A1 Imidazole derivatives as cyp17 inhibitors for the treatment of cancer
1 ... 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 ... 7860